Cimetidine synergizes with Praziquantel to enhance the immune response of HBV DNA vaccine via activating cytotoxic CD8⁺ T cell

References

• Rehermann B, Nascimbeni M. Immunology of hepatitis B virus and hepatitis C virus infection. Nat Rev Immunol 2005; 5:215 - 29; http://dx.doi.org/10.1038/nri1573; PMID: 15738952
   PubMed Web of Science ®Google Scholar
• Lok AS. Chronic hepatitis B. N Engl J Med 2002; 346:1682 - 3; http://dx.doi.org/10.1056/NEJM200205303462202; PMID: 12037146
   PubMed Web of Science ®Google Scholar
• Chan CY, Lee SD, Lo KJ. Legend of hepatitis B vaccination: the Taiwan experience. J Gastroenterol Hepatol 2004; 19:121 - 6; http://dx.doi.org/10.1111/j.1440-1746.2004.03153.x; PMID: 14731119
   PubMed Web of Science ®Google Scholar
• van Zonneveld M, Honkoop P, Hansen BE, Niesters HG, Darwish Murad S, de Man RA, Schalm SW, Janssen HL. Long-term follow-up of alpha-interferon treatment of patients with chronic hepatitis B. Hepatology 2004; 39:804 - 10; http://dx.doi.org/10.1002/hep.20128; PMID: 14999700
   PubMed Web of Science ®Google Scholar
• Chan HL, Tang JL, Tam W, Sung JJ. The efficacy of thymosin in the treatment of chronic hepatitis B virus infection: a meta-analysis. Aliment Pharmacol Ther 2001; 15:1899 - 905; http://dx.doi.org/10.1046/j.1365-2036.2001.01135.x; PMID: 11736720
   PubMed Web of Science ®Google Scholar
• Papatheodoridis GV, Dimou E, Papadimitropoulos V. Nucleoside analogues for chronic hepatitis B: antiviral efficacy and viral resistance. Am J Gastroenterol 2002; 97:1618 - 28; http://dx.doi.org/10.1111/j.1572-0241.2002.05819.x; PMID: 12135009
   PubMed Web of Science ®Google Scholar
• Wong DK, Cheung AM, O’Rourke K, Naylor CD, Detsky AS, Heathcote J. Effect of alpha-interferon treatment in patients with hepatitis B e antigen-positive chronic hepatitis B. A meta-analysis. Ann Intern Med 1993; 119:312 - 23; http://dx.doi.org/10.7326/0003-4819-119-4-199308150-00011; PMID: 8328741
   PubMed Web of Science ®Google Scholar
• MacGregor RR, Boyer JD, Ugen KE, Lacy KE, Gluckman SJ, Bagarazzi ML, Chattergoon MA, Baine Y, Higgins TJ, Ciccarelli RB, et al. First human trial of a DNA-based vaccine for treatment of human immunodeficiency virus type 1 infection: safety and host response. J Infect Dis 1998; 178:92 - 100; http://dx.doi.org/10.1086/515613; PMID: 9652427
   PubMed Web of Science ®Google Scholar
• Kutzler MA, Weiner DB. DNA vaccines: ready for prime time?. Nat Rev Genet 2008; 9:776 - 88; http://dx.doi.org/10.1038/nrg2432; PMID: 18781156
   PubMed Web of Science ®Google Scholar
• Chow YH, Huang WL, Chi WK, Chu YD, Tao MH. Improvement of hepatitis B virus DNA vaccines by plasmids coexpressing hepatitis B surface antigen and interleukin-2. J Virol 1997; 71:169 - 78; PMID: 8985336
   PubMed Web of Science ®Google Scholar
• Mancini M, Hadchouel M, Davis HL, Whalen RG, Tiollais P, Michel ML. DNA-mediated immunization in a transgenic mouse model of the hepatitis B surface antigen chronic carrier state. Proc Natl Acad Sci USA 1996; 93:12496 - 501; http://dx.doi.org/10.1073/pnas.93.22.12496; PMID: 8901610
   PubMed Web of Science ®Google Scholar
• Davis HL, McCluskie MJ, Gerin JL, Purcell RH. DNA vaccine for hepatitis B: evidence for immunogenicity in chimpanzees and comparison with other vaccines. Proc Natl Acad Sci U S A 1996; 93:7213 - 8; http://dx.doi.org/10.1073/pnas.93.14.7213; PMID: 8692971
   PubMed Web of Science ®Google Scholar
• Tacket CO, Roy MJ, Widera G, Swain WF, Broome S, Edelman R. Phase 1 safety and immune response studies of a DNA vaccine encoding hepatitis B surface antigen delivered by a gene delivery device. Vaccine 1999; 17:2826 - 9; http://dx.doi.org/10.1016/S0264-410X(99)00094-8; PMID: 10438052
   PubMed Web of Science ®Google Scholar
• Greenland JR, Letvin NL. Chemical adjuvants for plasmid DNA vaccines. Vaccine 2007; 25:3731 - 41; http://dx.doi.org/10.1016/j.vaccine.2007.01.120; PMID: 17350735
   PubMed Web of Science ®Google Scholar
• Geng S, Zhong Y, Wang S, Liu H, Zou Q, Xie X, Li C, Yu Q, He Z, Wang B. Amiloride enhances antigen specific CTL by faciliting HBV DNA vaccine entry into cells. PLoS One 2012; 7:e33015; http://dx.doi.org/10.1371/journal.pone.0033015; PMID: 22438887
   PubMedGoogle Scholar
• Jin H, Li Y, Ma Z, Zhang F, Xie Q, Gu D, Wang B. Effect of chemical adjuvants on DNA vaccination. Vaccine 2004; 22:2925 - 35; http://dx.doi.org/10.1016/j.vaccine.2003.12.026; PMID: 15246629
   PubMed Web of Science ®Google Scholar
• Cioli D, Pica-Mattoccia L.. Praziquantel. Parasitology Research 2003; 90:Supp 1 S3 9; PMID: 12811543
   PubMed Web of Science ®Google Scholar
• Pearson RD, Guerrant RL. Praziquantel: a major advance in anthelminthic therapy. Ann Intern Med 1983; 99:195 - 8; http://dx.doi.org/10.7326/0003-4819-99-2-195; PMID: 6881777
   PubMed Web of Science ®Google Scholar
• Zou Q, Yao X, Feng J, Yin Z, Flavell R, Hu Y, Zheng G, Jin J, Kang Y, Wu B, et al. Praziquantel facilitates IFN-γ-producing CD8+ T cells (Tc1) and IL-17-producing CD8+ T cells (Tc17) responses to DNA vaccination in mice. PLoS One 2011; 6:e25525; http://dx.doi.org/10.1371/journal.pone.0025525; PMID: 21998665
   PubMedGoogle Scholar
• Zou Q, Hu Y, Xue J, Fan X, Jin Y, Shi X, Meng D, Wang X, Feng C, Xie X, et al. Use of praziquantel as an adjuvant enhances protection and Tc-17 responses to killed H5N1 virus vaccine in mice. PLoS One 2012; 7:e34865; http://dx.doi.org/10.1371/journal.pone.0034865; PMID: 22529945
   PubMedGoogle Scholar
• Bodemar G, Walan A. Maintenance treatment of recurrent peptic ulcer by cimetidine. Lancet 1978; 1:403 - 7; http://dx.doi.org/10.1016/S0140-6736(78)91200-X; PMID: 75439
   PubMed Web of Science ®Google Scholar
• O’Mahony L, Akdis M, Akdis CA. Regulation of the immune response and inflammation by histamine and histamine receptors. J Allergy Clin Immunol 2011; 128:1153 - 62; http://dx.doi.org/10.1016/j.jaci.2011.06.051; PMID: 21824648
   PubMed Web of Science ®Google Scholar
• Li MJ, Lei JH, Wang T, Lu SJ, Guan F, Liu WQ, Li YL. Cimetidine enhances the protective effect of GST DNA vaccine against Schistosoma japonicum. Exp Parasitol 2011; 128:427 - 32; http://dx.doi.org/10.1016/j.exppara.2011.05.012; PMID: 21624364
   PubMed Web of Science ®Google Scholar
• Wang J, Su B, Ding Z, Du X, Wang B. Cimetidine enhances immune response of HBV DNA vaccination via impairment of the regulatory function of regulatory T cells. Biochem Biophys Res Commun 2008; 372:491 - 6; http://dx.doi.org/10.1016/j.bbrc.2008.04.191; PMID: 18502198
   PubMed Web of Science ®Google Scholar
• Steiner K, Garbe A, Diekmann HW, Nowak H. The fate of praziquantel in the organism I. Pharmacokinetics in animals. Eur J Drug Metab Pharmacokinet 1976; 1:85 - 95; http://dx.doi.org/10.1007/BF03189262
   Google Scholar
• Knodell RG, Browne DG, Gwozdz GP, Brian WR, Guengerich FP. Differential inhibition of individual human liver cytochromes P-450 by cimetidine. Gastroenterology 1991; 101:1680 - 91; PMID: 1955133
   PubMed Web of Science ®Google Scholar
• Dachman WD, Adubofour KO, Bikin DS, Johnson CH, Mullin PD, Winograd M. Cimetidine-induced rise in praziquantel levels in a patient with neurocysticercosis being treated with anticonvulsants. J Infect Dis 1994; 169:689 - 91; http://dx.doi.org/10.1093/infdis/169.3.689; PMID: 8158054
   PubMed Web of Science ®Google Scholar
• Grabbe S, Schwarz T. Immunoregulatory mechanisms involved in elicitation of allergic contact hypersensitivity. Immunol Today 1998; 19:37 - 44; http://dx.doi.org/10.1016/S0167-5699(97)01186-9; PMID: 9465487
   PubMedGoogle Scholar
• Maini MK, Boni C, Ogg GS, King AS, Reignat S, Lee CK, Larrubia JR, Webster GJM, McMichael AJ, Ferrari C, et al. Direct ex vivo analysis of hepatitis B virus-specific CD8(+) T cells associated with the control of infection. Gastroenterology 1999; 117:1386 - 96; http://dx.doi.org/10.1016/S0016-5085(99)70289-1; PMID: 10579980
   PubMed Web of Science ®Google Scholar
• Alatrakchi N, Koziel M. Regulatory T cells and viral liver disease. J Viral Hepat 2009; 16:223 - 9; http://dx.doi.org/10.1111/j.1365-2893.2009.01081.x; PMID: 19222744
   PubMed Web of Science ®Google Scholar
• Xu D, Fu J, Jin L, Zhang H, Zhou C, Zou Z, Zhao JM, Zhang B, Shi M, Ding X, et al. Circulating and liver resident CD4+CD25+ regulatory T cells actively influence the antiviral immune response and disease progression in patients with hepatitis B. J Immunol 2006; 177:739 - 47; PMID: 16785573
   PubMed Web of Science ®Google Scholar
• Furuichi Y, Tokuyama H, Ueha S, Kurachi M, Moriyasu F, Kakimi K. Depletion of CD25+CD4+T cells (Tregs) enhances the HBV-specific CD8+ T cell response primed by DNA immunization. World J Gastroenterol 2005; 11:3772 - 7; PMID: 15968737
   PubMed Web of Science ®Google Scholar
• Chisari FV, Pinkert CA, Milich DR, Filippi P, McLachlan A, Palmiter RD, Brinster RL. A transgenic mouse model of the chronic hepatitis B surface antigen carrier state. Science 1985; 230:1157 - 60; http://dx.doi.org/10.1126/science.3865369; PMID: 3865369
   PubMed Web of Science ®Google Scholar
• Kakimi K, Isogawa M, Chung J, Sette A, Chisari FV. Immunogenicity and tolerogenicity of hepatitis B virus structural and nonstructural proteins: implications for immunotherapy of persistent viral infections. J Virol 2002; 76:8609 - 20; http://dx.doi.org/10.1128/JVI.76.17.8609-8620.2002; PMID: 12163580
   PubMed Web of Science ®Google Scholar
• Liang M, Ma S, Hu X, Zhou B, Zhang J, Chen J, Wang Z, Sun J, Zhu X, Abbott W, et al. Cellular immune responses in patients with hepatitis B surface antigen seroclearance induced by antiviral therapy. Virol J 2011; 8:69; http://dx.doi.org/10.1186/1743-422X-8-69; PMID: 21320337
   PubMed Web of Science ®Google Scholar
• Carey I, D’Antiga L, Bansal S, Longhi MS, Ma Y, Mesa IR, Mieli-Vergani G, Vergani D. Immune and viral profile from tolerance to hepatitis B surface antigen clearance: a longitudinal study of vertically hepatitis B virus-infected children on combined therapy. J Virol 2011; 85:2416 - 28; http://dx.doi.org/10.1128/JVI.01449-10; PMID: 21147914
   PubMed Web of Science ®Google Scholar
• Rehermann B, Lau D, Hoofnagle JH, Chisari FV. Cytotoxic T lymphocyte responsiveness after resolution of chronic hepatitis B virus infection. J Clin Invest 1996; 97:1655 - 65; http://dx.doi.org/10.1172/JCI118592; PMID: 8601631
   PubMed Web of Science ®Google Scholar
• Thimme R, Wieland S, Steiger C, Ghrayeb J, Reimann KA, Purcell RH, Chisari FV. CD8(+) T cells mediate viral clearance and disease pathogenesis during acute hepatitis B virus infection. J Virol 2003; 77:68 - 76; http://dx.doi.org/10.1128/JVI.77.1.68-76.2003; PMID: 12477811
   PubMed Web of Science ®Google Scholar
• Maini MK, Boni C, Lee CK, Larrubia JR, Reignat S, Ogg GS, King AS, Herberg J, Gilson R, Alisa A, et al. The role of virus-specific CD8(+) cells in liver damage and viral control during persistent hepatitis B virus infection. J Exp Med 2000; 191:1269 - 80; http://dx.doi.org/10.1084/jem.191.8.1269; PMID: 10770795
   PubMed Web of Science ®Google Scholar
• Sad S, Marcotte R, Mosmann TR. Cytokine-induced differentiation of precursor mouse CD8+ T cells into cytotoxic CD8+ T cells secreting Th1 or Th2 cytokines. Immunity 1995; 2:271 - 9; http://dx.doi.org/10.1016/1074-7613(95)90051-9; PMID: 7697544
   PubMed Web of Science ®Google Scholar
• Intlekofer AM, Banerjee A, Takemoto N, Gordon SM, Dejong CS, Shin H, Hunter CA, Wherry EJ, Lindsten T, Reiner SL. Anomalous type 17 response to viral infection by CD8+ T cells lacking T-bet and eomesodermin. Science 2008; 321:408 - 11; http://dx.doi.org/10.1126/science.1159806; PMID: 18635804
   PubMed Web of Science ®Google Scholar
• Phillips S, Chokshi S, Riva A, Evans A, Williams R, Naoumov NV. CD8(+) T cell control of hepatitis B virus replication: direct comparison between cytolytic and noncytolytic functions. J Immunol 2010; 184:287 - 95; http://dx.doi.org/10.4049/jimmunol.0902761; PMID: 19949099
   PubMed Web of Science ®Google Scholar
• Guidotti LG, Ishikawa T, Hobbs MV, Matzke B, Schreiber R, Chisari FV. Intracellular inactivation of the hepatitis B virus by cytotoxic T lymphocytes. Immunity 1996; 4:25 - 36; http://dx.doi.org/10.1016/S1074-7613(00)80295-2; PMID: 8574849
   PubMed Web of Science ®Google Scholar
• Appay V, Nixon DF, Donahoe SM, Gillespie GM, Dong T, King A, Ogg GS, Spiegel HM, Conlon C, Spina CA, et al. HIV-specific CD8(+) T cells produce antiviral cytokines but are impaired in cytolytic function. J Exp Med 2000; 192:63 - 75; http://dx.doi.org/10.1084/jem.192.1.63; PMID: 10880527
   PubMed Web of Science ®Google Scholar
• Tagawa Y, Sekikawa K, Iwakura Y. Suppression of concanavalin A-induced hepatitis in IFN-gamma(-/-) mice, but not in TNF-alpha(-/-) mice: role for IFN-gamma in activating apoptosis of hepatocytes. J Immunol 1997; 159:1418 - 28; PMID: 9233639
   PubMed Web of Science ®Google Scholar
• Roth E, Pircher H. IFN-γ promotes Fas ligand- and perforin-mediated liver cell destruction by cytotoxic CD8 T cells. J Immunol 2004; 172:1588 - 94; PMID: 14734739
   PubMed Web of Science ®Google Scholar
• Roth E, Pircher H. IFN-gamma promotes Fas ligand- and perforin-mediated liver cell destruction by cytotoxic CD8 T cells. J Immunol 2004; 172:1588 - 94; PMID: 14734739
   PubMed Web of Science ®Google Scholar
• Spanaus KS, Schlapbach R, Fontana A. TNF-alpha and IFN-gamma render microglia sensitive to Fas ligand-induced apoptosis by induction of Fas expression and down-regulation of Bcl-2 and Bcl-xL. Eur J Immunol 1998; 28:4398 - 408; http://dx.doi.org/10.1002/(SICI)1521-4141(199812)28:12<4398::AID-IMMU4398>3.0.CO;2-Y; PMID: 9862377
   PubMed Web of Science ®Google Scholar
• Yeh N, Glosson NL, Wang N, Guindon L, McKinley C, Hamada H, Li Q, Dutton RW, Shrikant P, Zhou B, et al. Tc17 cells are capable of mediating immunity to vaccinia virus by acquisition of a cytotoxic phenotype. J Immunol 2010; 185:2089 - 98; http://dx.doi.org/10.4049/jimmunol.1000818; PMID: 20624947
   PubMed Web of Science ®Google Scholar
• Hinrichs CS, Kaiser A, Paulos CM, Cassard L, Sanchez-Perez L, Heemskerk B, Wrzesinski C, Borman ZA, Muranski P, Restifo NP. Type 17 CD8+ T cells display enhanced antitumor immunity. Blood 2009; 114:596 - 9; http://dx.doi.org/10.1182/blood-2009-02-203935; PMID: 19471017
   PubMed Web of Science ®Google Scholar
• Wu B, Zou Q, Hu Y, Wang B. Interleukin-22 as a molecular adjuvant facilitates IL-17-producing CD8+ T cell responses against a HBV DNA vaccine in mice. Hum Vaccin Immunother 2013; 9:2133 - 41; http://dx.doi.org/10.4161/hv.26047; PMID: 23941891
   PubMed Web of Science ®Google Scholar
• Workman CJ, Szymczak-Workman AL, Collison LW, Pillai MR, Vignali DA. The development and function of regulatory T cells. Cell Mol Life Sci 2009; 66:2603 - 22; http://dx.doi.org/10.1007/s00018-009-0026-2; PMID: 19390784
   PubMed Web of Science ®Google Scholar
• Stoop JN, van der Molen RG, Baan CC, van der Laan LJ, Kuipers EJ, Kusters JG, Janssen HL. Regulatory T cells contribute to the impaired immune response in patients with chronic hepatitis B virus infection. Hepatology 2005; 41:771 - 8; http://dx.doi.org/10.1002/hep.20649; PMID: 15791617
   PubMed Web of Science ®Google Scholar
• Vignali DA, Collison LW, Workman CJ. How regulatory T cells work. Nat Rev Immunol 2008; 8:523 - 32; http://dx.doi.org/10.1038/nri2343; PMID: 18566595
   PubMed Web of Science ®Google Scholar
• Elenkov IJ, Webster E, Papanicolaou DA, Fleisher TA, Chrousos GP, Wilder RL. Histamine potently suppresses human IL-12 and stimulates IL-10 production via H2 receptors. J Immunol 1998; 161:2586 - 93; PMID: 9725260
   PubMed Web of Science ®Google Scholar
• Watanabe K, Mwinzi PN, Black CL, Muok EM, Karanja DM, Secor WE, Colley DG. T regulatory cell levels decrease in people infected with Schistosoma mansoni on effective treatment. Am J Trop Med Hyg 2007; 77:676 - 82; PMID: 17978070
   PubMed Web of Science ®Google Scholar
• Zou Q, Zhong Y, Su H, Kang Y, Jin J, Liu Q, Geng S, Zhao G, Wang B. Enhancement of humoral and cellular responses to HBsAg DNA vaccination by immunization with praziquantel through inhibition TGF-beta/Smad2,3 signaling. Vaccine 2010; 28:2032 - 8; http://dx.doi.org/10.1016/j.vaccine.2009.10.101; PMID: 20188260
   PubMed Web of Science ®Google Scholar
• Li J, Qiu SJ, She WM, Wang FP, Gao H, Li L, Tu CT, Wang JY, Shen XZ, Jiang W. Significance of the balance between regulatory T (Treg) and T helper 17 (Th17) cells during hepatitis B virus related liver fibrosis. PLoS One 2012; 7:e39307; http://dx.doi.org/10.1371/journal.pone.0039307; PMID: 22745730
   PubMed Web of Science ®Google Scholar
• Li J, Wu W, Peng G, Chen F, Bai M, Zheng M, Chen Z. HBcAg induces interleukin-10 production, inhibiting HBcAg-specific Th17 responses in chronic hepatitis B patients. Immunol Cell Biol 2010; 88:834 - 41; http://dx.doi.org/10.1038/icb.2010.63; PMID: 20498672
   PubMed Web of Science ®Google Scholar
• Zhang JY, Song CH, Shi F, Zhang Z, Fu JL, Wang FS. Decreased ratio of Treg cells to Th17 cells correlates with HBV DNA suppression in chronic hepatitis B patients undergoing entecavir treatment. PLoS One 2010; 5:e13869; http://dx.doi.org/10.1371/journal.pone.0013869; PMID: 21079784
   PubMedGoogle Scholar
• Zhang W, Wang J, Su B, Li R, Ding Z, Kang Y, Wang B. Cimetidine augments Th1/Th2 dual polarized immune responses to recombinant HBV antigens. Vaccine 2011; 29:4862 - 8; http://dx.doi.org/10.1016/j.vaccine.2011.03.091; PMID: 21481324
   PubMed Web of Science ®Google Scholar
• Babinet C, Farza H, Morello D, Hadchouel M, Pourcel C. Specific expression of hepatitis B surface antigen (HBsAg) in transgenic mice. Science 1985; 230:1160 - 3; http://dx.doi.org/10.1126/science.3865370; PMID: 3865370
   PubMed Web of Science ®Google Scholar
• Du X, Zheng G, Jin H, Kang Y, Wang J, Xiao C, Zhang S, Zhao L, Chen A, Wang B. The adjuvant effects of co-stimulatory molecules on cellular and memory responses to HBsAg DNA vaccination. J Gene Med 2007; 9:136 - 46; http://dx.doi.org/10.1002/jgm.1004; PMID: 17310492
   PubMed Web of Science ®Google Scholar